Shanghai, China

Dongping Hu

This inventor holds 1 USPTO granted patent. Top assignee: The Second Military Medical University, the People's Liberation Army. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongping Hu. Retrieved from https://idiyas.com/inventor/dongping-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongping Hu

Introduction

Dongping Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is recognized for its potential applications in medical science.

Latest Patents

Dongping Hu holds a patent for the invention titled "P28GANK monoclonal antibody and peptides for preparation thereof and use thereof." This invention provides the sequences of two polypeptides comprising the amino acid sequences as shown in SEQ ID NO:1 and SEQ ID NO:2. These sequences can be utilized for the preparation of monoclonal antibodies against human p28. The invention also details the monoclonal antibodies against human p28 and their various uses. He has 1 patent to his name.

Career Highlights

Dongping Hu is affiliated with the Second Military Medical University, which is part of the People's Liberation Army. His role at this institution has allowed him to engage in cutting-edge research and development in the field of medical biotechnology.

Collaborations

He has collaborated with notable colleagues, including Hongyang Wang and Yao Liang Chen. Their combined expertise has contributed to advancements in their research projects.

Conclusion

Dongping Hu's innovative work in monoclonal antibodies showcases his dedication to advancing medical science. His contributions are vital for future developments in biotechnology and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…